Comunicati.net - Comunicati pubblicati - Comune di Ferrara Comunicati.net - Comunicati pubblicati - Comune di Ferrara Tue, 13 Apr 2021 21:34:54 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/1 The Endoscopes Market To Witness An Extensive Growth With A CAGR Of 6% Mon, 12 Apr 2021 08:28:23 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701811.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701811.html persistencemarketresearch persistencemarketresearch Endoscopes are gaining significant demand for arthroscopy, bronchoscopy, colonoscopy, and cystoscopy procedures. The shift toward minimally-invasive surgeries compared to open surgeries is likely to increase demand for endoscopes. Key stakeholders are introducing capsule endoscopes, robot-assisted endoscopes, and disposable endoscopes to overcome few drawbacks of conventional endoscopes.

For instance, in July 2015, Medrobotics Corporation received FDA clearance for its Flex® Robotic System for sale in the United States. Also, international medical device manufactures are concentrating on entering the capsule and robot-assisted endoscopes market. For example, Medtronic now holds a leading market share in the capsule endoscopes market after its acquisition of Given Imaging Ltd.

The global endoscopes market was valued at US$ 11.8 Bn in 2019, and is expected to witness a CAGR of 6% during the forecast period (20202030).

Strategizing The Moves For The Next Decade? See Through Sample Of Endoscopes Market Report! https://www.persistencemarketresearch.co/samples/31385

Companies covered in Endoscopes Market Report

  • Medtronic Plc.
  • Olympus Corporation
  • KARL STORZ SE & Co. KG
  • Johnson & Johnson
  • Fujifilm Holdings Corporation
  • Richard Wolf GmbH
  • Braun Melsungen Ag
  • Stryker Corporation
  • PENTAX Medical
  • CONMED Corporation
  • Boston Scientific Corporation
  • Smith & Nephew PLC

Starting With The New Decade On A Diligent Note In The Endoscopes Market? https://www.persistencemarketresearch.co/methodology/31385

Key Takeaways of Endoscopes Market Study

  • Flexible endoscopes occupied nearly 60% of value share in the endoscopes market in 2019, owing to increasing adoption over rigid endoscopes. Flexible endoscopes provide better safety, greater efficacy, and better accessibility to internal organs as compared to rigid endoscopes.
  • Gastrointestinal (GI) endoscopy accounted for the highest value share in the global endoscopes market, on the back of increasing annual gastrointestinal and colonoscopy procedures.
  • Bronchoscopy registered the highest growth rate owing to rising number of respiratory disorders and introduction of new endoscopy products for bronchoscopy.
  • Reusable endoscopes accounted for more than three-fourth of the value share in global endoscopes market. Moreover, the disposable segment registered a higher growth rate as compared to the reusable segment, with the growing demand for procedure-specific endoscopes and benefits of sterilization cost reduction.
  • Hospitals hold a major share in the global endoscopes market, owing to large-scale adoption of endoscopic surgeries and favorable reimbursement policies for patients who visit hospitals as compared to outpatient centers.
  • North America holds a prominent revenue share in the global endoscopes market, as a higher number of endoscopic surgeries as performed each year in the country.

“Growing gastrointestinal and colorectal cancer cases and higher acceptance of minimally-invasive procedures are likely to pace up market growth. Demand for endoscopes will continue to pick pace with the introduction of new technologies for accurate visualization,” says a PMR analyst.

COVID-19 Impact on Endoscopes Market

The COVID-19 outbreak is asserting players in the endoscope market to restructure their working methods to suit drastic market changes. With governments implementing strict norms on physical movements and emphasis on social distancing, production is being significantly affected. Furthermore, shortage of manpower and travel restrictions are disrupting the supply chain, thereby affecting the overall workflow of the market. However, endoscopes, being an essential commodity in the healthcare industry, are likely to overcome these shortcomings caused by the pandemic.

On the back of persistent demand for endoscopes from healthcare institutions to detect cardiovascular diseases - which continue to cause a significant number of deaths all over the globe - the endoscopes market is likely to mitigate heavy damage. On this premise, Cook Medical, a prominent endoscopes manufacturer, stated that, it's keeping production running with the available workforce and ensuring that the supply of essential devices is unhindered.

How About Obtaining Insights About The Region To Enter Concerning The Endoscopes Market? Press The “Purchase Now” Button To Have Our Endoscopes Market Report! https://www.persistencemarketresearch.com/checkout/31385

Product Portfolio Expansion and Distribution Partnerships - Key Strategies of Leading Manufacturers

Endoscope manufacturers are focusing on product portfolio expansion through partnerships and new product launches. For instance, in May 2018, FUJIFILM Holdings Corporation launched the EB-530P Slim Video Bronchoscope and Radial Probe EBUS System (PB2020-M).

Moreover, manufacturers are moving toward distribution agreements and partnerships to expand their presence in the global market. For example, in June 2018, CapsoVision announced a U.S. distribution partnership with Pentax Medical for capsule endoscopy solutions - CapsoCam Plus and CapsoCloud - across the country.

More Valuable Insights on Endoscopes Market

Persistence Market Research offers a unique perspective and actionable insights on endoscopes in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, on the basis of product (rigid endoscopes, flexible endoscopes, capsule endoscopes, and robot-assisted endoscopes), application (gastrointestinal (GI) endoscopy, laparoscopy, arthroscopy, obstetrics/gynecology endoscopy, urology endoscopy (cystoscopy), ENT endoscopy, bronchoscopy, mediastinoscopy, and others), usability (reusable and disposable), and end user (hospitals, ambulatory surgery centers, and specialty clinics), across seven major regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Sleep Aid Devices Market To Rescind With A CAGR Of 4.9% Mon, 12 Apr 2021 08:28:00 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701809.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701809.html persistencemarketresearch persistencemarketresearch According to the American Sleep Association, around 50-70 million adults in the U.S. are suffering from sleep disorders, 48.0% of the U.S. adults report snoring, and approximately 5.9 million U.S. adults were diagnosed with obstructive sleep apnea (OSA).

In Latin America, the prevalence of OSA was 23.5% in 2013. Sleep aid devices are considered as useful tools for the treatment of sleep disorders. According to the latest research by Persistence Market Research (PMR), the global sleep aid devices market is anticipated to account for over US$ 29,200 Mn, in terms of value, by 2026 end. The report on the sleep aid devices market further projects significant growth potential with CAGR at 4.9% through 2026.

Get Going With Sample Of Sleep Aid Devices Market Report! https://www.persistencemarketresearch.co/samples/25411

Company Profile

  • ResMed Inc.
  • Fisher & Paykel Healthcare Limited
  • Drive DeVilbiss Healthcare LLC
  • Koninklijke Philips N.V.
  • Sleep Number Corporation
  • Responsive Surface Technology LLC
  • Eight Sleep Inc.
  • Simmons Bedding Company LLC
  • Electromedical Products International, Inc.
  • Kingsdown, Inc.
  • Ebb Therapeutics
  • Sleepace Inc.
  • Others.

Rising stress levels and the rapid increase in sleep disorders such as, insomnia, sleep apnea, restless legs syndrome, narcolepsy, and sleep deprivation have created a need for more advanced sleep aid devices. Various government and non-government organizations such as Circadian Sleep Disorders Network and American Sleep Apnea Association (ASAA) are conducting various awareness programs to increase awareness regarding the importance of ample sleep and usage of sleep aid devices.

The initiatives taken by sleep associations and government authorities are promoting the demand for sleep disorder treatment. This would result in an increasing wave of demand for sleep aid devices.

How About Re-Inventing The Methodical Wheel In The Sleep Aid Devices Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/25411

The rise in geriatric population is expected to contribute to the growth of sleep aid devices market. As per the NIH-funded Census Bureau report in 2016, around 8.5% of the world population was aged 65 or above and by 2050 this percentage is expected to grow to around 17%.

The prevalence of several lifestyle diseases such as atherosclerosis, heart disease, stroke, obesity, type 2 diabetes, and diseases associated with smoking, alcohol and drug abuse is rising globally. The rise in geriatric population and other lifestyle-related diseases is consequently expected to impact the growth of the sleep aid devices market in a positive way.

Disposable income in developing economies is increasing, as a result, people are opting for safe and advanced sleep aid devices. Moreover, due to the rise in disposable income, people now can afford the high-cost devices. Such favorable conditions have provided an excellent growth opportunity for the manufacturers of sleep aid devices to connect with potential customers.

Persistence Market Research (PMR) has segmented the sleep aid devices market based on product type, indication, end user, and region.

The product type segment of the sleep aid devices market is segmented into Positive Air Pressure Devices, Adaptive Servo-Ventilation (ASV) Devices, Mattresses and Pillows, Smart Sleeping Equipment, and Other Sleep Solutions. Smart sleeping equipment are technologically-advanced sleep aid devices, which track sleep and give information about the quality of sleep a person had with the help of a mobile application.

Along with sleep data, they also have some additional features such as onboard temperature control, smart home integration, and can analyze heart and breathing rate to help a person sleep properly. The smart sleeping equipment segment in the sleep aid devices market is expected to witness noteworthy growth in terms of revenue owing to the rapid increase in demand for safe sleep aid devices.

Keeping A Tab On Key Players In The Sleep Aid Devices Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Sleep Aid Devices Market Report! https://www.persistencemarketresearch.com/checkout/25411

By indication, sleep aid devices can be segmented as sleep aid devices for insomnia, sleep aid devices for sleep apnea, sleep aid devices for restless leg syndrome, sleep aid devices for narcolepsy, and sleep aid devices for sleep deprivation. Insomnia is the most common sleep disorder among these, with short-term issues reported by about 30% of adults and chronic insomnia by 10% in the U.S.

North America and Europe sleep aid devices markets will continue to dominate owing to favorable reimbursement coverage and increasing per capita healthcare expenditure. The Asia Pacific and Latin America sleep aid devices market is expected to grow at a high growth rate due to active healthcare landscape and favorable government policies for startup companies.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Healthcare Cloud Computing Market To Witness A Penurious CAGR Of 18.9% Mon, 12 Apr 2021 08:27:38 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701808.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701808.html persistencemarketresearch persistencemarketresearch The research report on healthcare cloud computing market includes current market scenario analysis as well as a revised forecast for a period of eight years. According to a recent market report published by Persistence Market Research titled, “Healthcare Cloud Computing Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)” the global healthcare cloud computing market is anticipated to be valued at US$ 7791.4 Mn in 2025, and is expected to register a CAGR of 18.9% from 2017 to 2025.

Increasing demand for better healthcare facilities and Rising investments by healthcare IT players are major factors driving growth of the global healthcare cloud computing market.

Get Going With Sample Of Healthcare Cloud Computing Market Report! https://www.persistencemarketresearch.co/samples/19390

Company Profiles

  • Agfa -Gevaert N.V.
  • Athena Health Inc.
  • Care Cloud Corporation
  • CareStream Health Inc.
  • Dell Inc.
  • IBM Corporation
  • Oracle Corporation
  • Microsoft Corporation
  • GE Healthcare

How About Re-Inventing The Methodical Wheel In The Healthcare Cloud Computing Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/19390

Cloud refers to a prototype in which data is permanently stored on servers and accessed by clients with the help of different information systems such as computers, sensors, laptops, and others. Cloud computing refers to a process which involves delivering hosted services to clients.

Global Healthcare Cloud Computing Market: Segmentation & Forecast

Global healthcare cloud computing market is categorized on the basis of application, deployment model, by components, by service model and region. On the basis of application, the market is segmented as CIS and NCIS. The CIS segment is anticipated to register a CAGR of 20.3% during the forecast period.

The component segment is segmented into software, hardware, and services. On the basis of deployment model, the market is segmented as public cloud, private cloud, and hybrid cloud. Private cloud segment accounted for highest market share and was valued at US$ 2,504 Mn in 2016.

The service model segment is segmented as SaaS, Paas, and IaaS. The SaaS segment is poised to be highly lucrative in the coming years. This segment is estimated to reach a value of about US$ 25.4 Bn by 2025 end and is the fastest growing segment to register an exponential CAGR of 19.7% throughout the period of assessment, 2017-2025.

The PaaS segment is the smallest segment with a low estimate of US$ 360.3 Mn in 2017 and is expected to reach US$ 1.2 Bn by 2025 end. By component, the software segment is projected to grow at a higher rate to register value CAGR of 19.2% throughout the period of forecast and is the largest segment in terms of value share. It is estimated to reach a valuation of more than US$ 21 Bn by the end of 2025.

Keeping A Tab On Key Players In The Healthcare Cloud Computing Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Healthcare Cloud Computing Market Report! https://www.persistencemarketresearch.com/checkout/19390

Global Healthcare Cloud Computing Market: Regional Forecast

This report also covers drivers, restraints and trends driving each segment and offers analysis and insights regarding the potential of healthcare cloud computing market in regions including North America, Latin America, Europe, Asia Pacific, and Middle East and Africa.

Among these regions, North America accounted for the largest market share in 2016. Moreover, North America region is also expected to register a healthy CAGR of 19.6% during the forecast period.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Gene Expression Analysis Market To Mark Robustness In The Form Of A Robust CAGR 6% Mon, 12 Apr 2021 08:27:16 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701807.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701807.html persistencemarketresearch persistencemarketresearch According to the recently-published report by Persistence Market Research, the global market for gene expression analysis will reflect a steady growth during the forecast period, 2017-2022. By the end of 2022, the global gene expression analysis market is predicted to surpass US$ 4,500 Mn valuation, reflecting a robust CAGR in terms of revenues.

The study throws a light on various factors influence the dynamics of global gene expression analysis market, and offers insightful projections, the highlights of which are mentioned below.

How About Looking Through The Sample Of Gene Expression Analysis Market Report? https://www.persistencemarketresearch.co/samples/17995

Company Profile

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • General Electric Company
  • Illumina, Inc.
  • Luminex Corporation
  • Oxford Gene Technology IP
  • PerkinElmer, Inc
  • QIAGEN NV
  • Roche Holding AG
  • Thermo Fisher Scientific, Inc

How About Step-By-Step Insights To Gene Expression Analysis Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/17995

Gene Expression Analysis Market: Regional Forecast

Through 2022, North America is anticipated to hold a leading position in the global market for gene expression analysis. Most of the companies operating in the expansion of global gene expression analysis market are based in the US.

Moreover, North American research institutes contributing to the field of functional genomics continue to support the development of new drugs derived from gene expression analysis studies. Drug discovery is a key application of gene expression analysis, and the US healthcare markets are observed as lucrative grounds for players in the global gene expression analysis market.

  • North America’s gene expression analysis market is pegged to be reach a billion dollar valuation by the end of 2017. The report projects that throughout the forecast period, the gene expression analysis market in North America will reflect a robust CAGR, wherein the US market will be observed as the largest contributor to this growth.
  • Europe is also expected to reflect impressive growth as the gene expression analysis market in this region is poised to create an incremental opportunity of over US$ 200 Mn between 2017 and 2022.
  • The gene expression analysis market in Asia-Pacific excluding Japan (APEJ) region is anticipated to record fastest growth. To the contrary, Japan’s gene expression analysis market is expected to reflect lowest CAGR during the forecast period.

Want To Keep A Tab On The Latest Findings In The Gene Expression Analysis Market? Purchase Our Gene Expression Analysis Market Report Now! https://www.persistencemarketresearch.com/checkout/17995

Widespread Adoption of Northern Blotting Technology

On the basis of technology, the report projects that northern blotting will be at the forefront of adoption, and will reflect highest share on global revenues of gene expression analysis market. DNA microarrays and PCR techniques are also projected to gain traction as preferred technologies used for synthesizing functional gene products through gene expression analysis.

Advancements in RNA-sequencing, 2-D gel electrophoresis, western blotting, immunoassays, ChIP, mass spectrometry and other technologies are also expected to influence the future prospects of global gene expression analysis market.

The report further projects that gene expression analysis will find higher traction in drug discovery & development applications. Towards the end of the forecast period, application of gene expression analysis in drug discovery & development is anticipated to procure over US$ 1,200 Mn in global revenues.

Concurrently, the demand for gene expression analysis products with low- to mid- plex capacity will also witness considerable uptake during the forecast period. The report also anticipates that sales of products – kits & reagents – will reflect a sizeable share on the value of global gene expression analysis market throughout the forecast period.

By the end of 2022, kits & reagents will register over one-third share on the global market revenues for gene expression analysis.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Compression Therapy Devices Market To Register A CAGR Of 5.2% Mon, 12 Apr 2021 08:26:53 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701806.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701806.html persistencemarketresearch persistencemarketresearch According to a new market report published by Persistence Market Research “Global Market Study on Compression Therapy - Asia to Witness Highest Growth by 2020”, the global compression therapy market was valued at USD 2,377.8 million in 2014 and is expected to expand at a CAGR of 5.2% from 2014 to 2020, to reach USD 3,232.3 million by 2020.

Compression therapy is a procedure entailing the delivery of an external force to tired and aching legs and other relevant anatomical targets where compression is required for management. This therapy is used to treat venous and lymphatic diseases such as lower limb edema, venous eczema, deep vein thrombosis, and diabetic foot ulcers.

How About Looking Through The Sample Of Compression Therapy Devices Market Report? https://www.persistencemarketresearch.co/samples/3064

Some of the major players in the compression therapy market:

  • SIGVARIS.
  • BSN medical GmbH.
  • PAUL HARTMANN AG.
  • Julius Zorn GmbH.
  • ArjoHuntleigh.
  • THUASNE.
  • Smith & Nephew plc.
  • medi GmbH & Co. KG.
  • Medtronic plc.

How About Step-By-Step Insights To Compression Therapy Devices Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/3064

Globally, the market for compression therapy is witnessing significant growth due to the increasing prevalence of diabetes, growth of the aging population, high incidence of sports injuries, rising awareness about various venous diseases, and the advanced features of compression therapy garments and devices.

However, inadequate reimbursement policies and the risk of complications associated with compression therapy systems inhibit the growth of the market. The global compression therapy market is anticipated to grow from an estimated USD 2,377.8 million in 2014 to USD 3,232.3 million by 2020 at a CAGR of 5.2% during the forecast period.

North America dominates the compression therapy market due to increasing numbers of sports injuries in the region. For instance, according to Safe Kids Worldwide, a global organization dedicated to preventing injuries in children, every year about 1.3 million cases of sports injuries among youngsters are registered in the U.S. Increasing prevalence of diabetes, aging population, and rising obesity are also supporting the growth of compression therapy market in North America.

Want To Keep A Tab On The Latest Findings In The Compression Therapy Devices Market? Purchase Our Compression Therapy Devices Market Report Now! https://www.persistencemarketresearch.com/checkout/3064

The compression therapy market in Europe is growing due to rising incidence of sports injuries in the region. According to the European Injury Database (IDB), approximately 4.5 million people above 15 years of age are treated in hospitals for sports injuries every year in the region. In addition, increasing the prevalence of diabetes and the growth of the aging population are also supporting the growth of the compression therapy market in Europe.

Asia is the fastest-growing region in the compression therapy market. According to the Asian Federation of Sports Medicine (AFSM), a part of International Federation of Sports Medicine (FIMS), on average 21,334 sports injuries occur every year in the region. Moreover, a growing aging population and increasing prevalence of diabetes are also supporting the growth of the compression therapy market in the region.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Dental Implants Market To Witness A Growth Of 9.7%, To Reach Mon, 12 Apr 2021 08:26:31 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701805.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701805.html persistencemarketresearch persistencemarketresearch According to a new market report published by Persistence Market Research “Global Market Study on Dental Implants - Asia Pacific to Witness Fastest Growth by 2020,” the global Dental implants market was valued at USD 4,508.9 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 7,879.5 million in 2020.

Globally, rising aging population has increases the demand for dental implants in the market. As a result, the market is expected to grow at a CAGR of about 9.7% from 2014 – 2020.

How About Looking Through The Sample Of Dental Implants Market Report? https://www.persistencemarketresearch.co/samples/2821

Some of the major companies operating in the market:

  • Institut Straumann AG.
  • Nobel Biocare.
  • DENTSPLY International Inc.
  • Zimmer dental Inc.
  • Danaher Corporation.
  • 3M Company.
  • Neoss International.
  • Ivoclar Vivadent AG.
  • OSSTEM IMPLANT.

How About Step-By-Step Insights To Dental Implants Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/2821

Some of the major drivers which help in increasing demand for dental implants are rising aging population and growing concern for oral healthcare. Rising demand for cosmetic dentistry also supports the growth of dental implants market. High cost of dental implants surgery in countries such as the U.S. and the U.K. supports the growth of medical tourism in different part of the world including Malaysia, Hungary, Costa Rica, and India.

However, limited reimbursements for dental implants surgery are restraining the growth of the dental implants market. Various technological advancements in dental implants such as Computer Aided Design (CAD), 3D imaging, mini dental implants, laser dentistry, sedation dentistry, and nanotechnology have improved dental surgical procedures.

Europe is the largest market for the global dental implants due to growing concern for oral hygiene, increasing clinical adoption of dental implants therapy and technological advancements. Some of the fastest growing markets for dental implants in Europe are the U.K., France and Germany. Titanium implants is the largest material based market and is expected to grow at a CAGR of about 9.8% from 2014 to 2020.

Want To Keep A Tab On The Latest Findings In The Dental Implants Market? Purchase Our Dental Implants Market Report Now! https://www.persistencemarketresearch.com/checkout/2821

The dental implants market in North America is expected to witness moderate growth attributed to aging population, rising awareness about oral health and technological advancement in dental implants surgery procedures. Adoption of advanced dentistry by North American people also plays important roles in driving the growth of the dental implants market.

According to the American Dental Hygienists’ Association (ADHA), approximately 75% of American adults were suffering from various forms of gum diseases in 2008. However, Asia Pacific is the fastest growing dental implants market. Growing concern about oral health and medical tourism are some factors driving the growth of the dental implant in the Asia Pacific market.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Alexandrite Laser Treatment Market To Quell Covid-19; To Reach US$ 285 Million Sun, 11 Apr 2021 15:28:40 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701726.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701726.html persistencemarketresearch persistencemarketresearch

Growing trend for aesthetic procedures has increased demand for permanent hair removal treatments. Alexandrite laser treatment is a popular choice for hair removal across the globe, and hence, rapidly rising popularity of permanent hair removal procedures will upsurge market growth over the coming years.

According to a latest report published by PMR, the global alexandrite laser treatment market is expected to witness a healthy CAGR of around 7% over the forecast period (2020 – 2030), to be valued around US$ 285 Mn by the end of 2030.

Strategizing The Moves For The Next Decade? See Through Sample Of Alexandrite Laser Treatment Market Report! https://www.persistencemarketresearch.co/samples/32045

Companies covered in Alexandrite Laser Treatment Market Report

  • Alma Lasers
  • Candela Medical
  • Cynosure, Inc.
  • Quanta Systems
  • El.En. (Asclepion Technologies)
  • Lutronic Corporation
  • Bison Medical
  • Lumenis
  • Lynton Laser
  • EL.EN. S.p.A. (Deka Mela S.r.l.)

Starting With The New Decade On A Diligent Note In The Alexandrite Laser Treatment Market? https://www.persistencemarketresearch.co/methodology/32045

 Key Takeaways from Alexandrite Laser Treatment Market Study    

  • Hair removal is the leading segment by indication in the global alexandrite laser treatment market. In 2019, 916,869 individuals had undergone hair removal treatments, and the trend is growing at a healthy growth rate.
  • North America is the leading region in the alexandrite laser treatment market, followed by Europe.
  • East and South Asia, including China, South Korea, Japan, India, and ASEAN countries, are the fastest-growing regions in the global alexandrite laser treatment market, due the rising demand for cosmetic procedures.
  • Alma Lasers, Cynosure, Inc., and Candela are amongst the leading players in the global alexandrite laser treatment market. These companies focus more on new product development and industry consolidation through M&A, collaborations, and partnerships to maintain a leadership position in the market.
  • Aesthetics and dermatology lead the alexandrite laser treatment application market; however, growing use of alexandrite lasers in dentistry makes it a lucrative segment.
  • Hospitals is the leading end user segment, and contributes more than 40% of all alexandrite laser treatments performed.

How About Obtaining Insights About The Region To Enter Concerning The Alexandrite Laser Treatment Market? Press The “Purchase Now” Button To Have Our Alexandrite Laser Treatment Market Report! https://www.persistencemarketresearch.com/checkout/32045

“Increasing burden of skin problems is expected to boost the global alexandrite laser treatment market,” says a PMR analyst.

Skin disease is considered as one of the leading causes of disease burden, affecting millions of people across the world. Acne is considered the most common skin problem in the U.S., affecting over 50 million people yearly. Acne causes significant physical changes, including permanent scarring. Furthermore, nearly 85% of people aged between 12 and 24 experience acne. The efficiency of alexandrite laser treatment and intense pulsed light (IPL) are widely accepted in aesthetic dermatology for the treatment of a variety of cutaneous conditions. Thus, rising prevalence of such skin problems is boosting the growth of the alexandrite laser treatment market.

Industry Consolidation – Key Strategy Adopted by Market Players

Manufacturers in the alexandrite laser treatment market are highly engaged in various industry consolidation activities such as mergers, acquisitions, and collaborations to increase their product range and distribution network, which creates huge growth opportunities for the growth of the alexandrite laser treatment market. In June 2018, Quanta System acquired Northwest Lineman College to support Quanta’s strategic plan for future growth.

Along with that, companies operating in the alexandrite laser treatment market are focusing on making different strategies to develop new products and expand their distribution. Manufacturers are also focusing on product distribution and collaboration agreements with other market players to hold a better position in the alexandrite laser treatment market. To gain maximum revenue from the market, they are entering into partnership agreements as an expansion strategy.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the alexandrite laser treatment in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030 on the basis of indication (hair removal, tattoo removal, vascular lesions, pigmented lesions, and others), application (aesthetic, dermatology, dentistry, urology, and others), and end user (hospitals, laser treatment centers, specialty clinics, and others), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Emergency Hospital Beds Market To Be Accelerated By Technology And Reach US$ 10 Billion Sun, 11 Apr 2021 15:28:18 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701725.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701725.html persistencemarketresearch persistencemarketresearch

High number of hospitalizations witnessed during the current COVID-19 pandemic along with routine hospitalizations will propel the growth of the global emergency hospital beds market over the period of 2020-2030. The current pandemic is not a standalone phenomenon but a part of a larger pattern of frequent epidemics that is evident from recent occurrences such as Ebola, Middle East Respiratory Syndrome (MERS), and many others.

The emergency hospital beds market includes a variety of products such as surgical beds, bariatric beds, critical care beds, emergency and transport stretchers, speciality stretchers, and others. Key manufacturers also offer various products based on different technologies such as electric-powered or manual stretchers.

Persistence Market Research estimates that, the global emergency hospital beds market will reach a valuation of US$ 10 Bn by the year 2030.

Want Insights To Emergency Hospital Beds Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/32044

Companies covered in Emergency Hospital Beds Market Report

  • Invacare Corporation
  • Hill-Rom Holdings Inc.
  • Stryker Corporation
  • LINET
  • Arjo
  • PARAMOUNT BED CO., LTD.
  • Howard Wright Limited
  • Midmark Corp
  • Joson-Care Enterprise Co., Ltd.
  • Stiegelmeyer GmbH & Co. KG
  • NOA Medical Industries Inc.
  • Novum Medical Products
  • Amico Corporation

Planning To Conclude Your Strategy On A Decisive Note In The Emergency Hospital Beds Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/32044

Key Takeaways from Emergency Hospital Beds Market Study

  • The speciality stretchers sub-segment within the stretchers segment is expected to be the most lucrative segment in the global emergency hospital beds market by the end of 2030.
  • By end user, the hospitals segment is expected to grow almost 1.5X over the years 2020 to 2030.
  • By region-wise segmentation, Europe is estimated to be the most attractive region in the global emergency hospital beds market.
  • Countries such as China, India, and Brazil have the potential to drive future growth in the global emergency hospital beds market, owing to the growing burden of infectious and chronic diseases, coupled with high demand for maternity beds.
  • The COVID-19 pandemic has resulted in increased hospitalizations across the world, which is giving added imputes to the growth of the emergency hospital beds market.

“Mounting occurrence of diseases coupled with rising incidence of road accident-related hospitalizations will propel the growth of the emergency hospital beds market over the coming period,” suggests a PMR analyst.

How About Knowing The Product/Technology Driving The Emergency Hospital Beds Market Before Investing Therein? Click The “Purchase Now” Button Of Our Emergency Hospital Beds Market Report! https://www.persistencemarketresearch.com/checkout/32044

Increasing Surgeries Due to Road Accidents, Births, & CVDs Remains Key Driving Factor

Rise in surgical procedures worldwide due to various reasons such as increased cardiovascular conditions, birth-associated procedures, and road accident-related procedures are the main reasons behind the growth of the surgical beds sub-segment in the emergency hospital beds market. For instance, UNICEF reported that, internationally, in 2018, more than half of the births were projected to have taken place in nine countries in emerging markets: India (69,070), China (44,760), Nigeria (20,210), Pakistan (14,910), Indonesia (13,370), the US (11,280), the Democratic Republic of Congo (9,400), Ethiopia (9,020), and Bangladesh (8,370).

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the emergency hospital beds market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for the period of 2020 – 2030, on the basis of product (beds [surgical beds, maternity beds, critical care beds, and bariatric beds] and stretchers [emergency and transport stretchers, procedural stretchers, and speciality stretchers]) and end user (hospitals, ambulatory surgical centres, and speciality clinics), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Disinfection Robots Market To Bank On Its Armory Of Product/Service Offerings By Reaching 10X Revenue Sun, 11 Apr 2021 15:27:56 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701724.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701724.html persistencemarketresearch persistencemarketresearch

Adoption of disinfection robots has increased rapidly after the outbreak of COVID-19. There has been an increase in the sale of disinfection robots by 400-600% across the globe. The novel coronavirus outbreak has also highlighted the inability of conventional techniques in disinfecting and sanitizing a facility, and this factor has rapidly driven the adoption of disinfection robots, as these robots can effectively disinfect hospitals and other public areas with minimal human interference.

Many companies have got a stamp of approval for their products to fight the COVID-19 battle. Approvals for different products further enhances the attention given by end users. Many providers of disinfection services have entered the disinfection robots market, and many more are coming in with their innovative and advanced technologies and software. With the coronavirus outbreak, manufacturers of disinfection robots will be able to cash in on vast opportunities to make their business stand out from competitors by coming up with a broad range of products.

As per PMR analysis, the global disinfection robots market is set to surge at a high CAGR of 27% over the next ten years, expanding 10X in value over the same period of time.

Get Going With Sample Of Disinfection Robots Market Report! https://www.persistencemarketresearch.co/samples/22822

Companies covered in Disinfection Robot Market Report

  • Xenex Disinfection Services, LLC
  • Nevoa Inc.
  • Ultraviolet Devices, Inc.
  • Rubedo Sistemos
  • Blue Ocean Robotics ApS
  • Bioquell, Inc.
  • Skytron, LLC.
  • The Clorox Company (Procter & Gamble)
  • OMRON Corporation
  • Fetch Robotics, Inc.
  • Geek+
  • Akara Robotics Ltd.
  • FINSEN TECHNOLOGIES LTD.
  • TMI Robotics Co., Ltd
  • SESTO Robotics
  • OTSAW

How About Re-Inventing The Methodical Wheel In The Disinfection Robots Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/22822

Key Takeaways from Disinfection Robots Market Study

  • Based on product, with market value share of over 3/4, UV light robots will be the most profitable segment, due to higher adoption coupled with superior disinfection efficacy as compared to hydrogen peroxide vapor (HPV) robots.
  • In terms of technology, fully autonomous robots is the leading segment, owing to higher efficiency and low human interaction while disinfecting as compared to semi-autonomous robots.
  • North America is the most lucrative region in the global disinfection robots market, with around 45% of the market share, owing to higher adoption of these devices in the region.
  • As end users, hospitals is most profitable segment with around 2/3 of the market value share, due to higher demand for disinfection robots in order to reduce the risk of hospital-acquired infections.

“Increasing demand for disinfection robots to reduce the spread of healthcare facility-associated infections, increasing technological advancements, and growing concerns about maintaining environmental hygiene after the COVID-19 outbreak are some of the factors expected to contribute in propelling the growth of the global disinfection robots market for years to come,” says a PMR analyst.

Keeping A Tab On Key Players In The Disinfection Robots Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Disinfection Robots Market Report! https://www.persistencemarketresearch.com/checkout/22822

Key Strategy amongst Market Players

Key players in the disinfection robots market focusing on strengthening their market presence through a variety of advanced technologies and software with the development of new platforms. Manufacturers are highly focusing on developing products to meet every budget of end users. Leading players are trying to provide their products in middle and lower income countries, and local players are focusing on increasing their product reach with the launch of various types of disinfection robots. Market players are focusing on launching facility-specific disinfection robots in order to enhance the efficacy of disinfection procedures and increasing the adoption of their products.

Growing Trends in Disinfection Robots Market Space

Manufacturers in the disinfection robots market space are highly focusing on developing facility-specific disinfection robots for reducing the cost of manual cleaning, such as robots for commercial spaces and offices. Companies are understanding the demands of various end users and are effectively providing their services based on applications. Manufacturers are modifying predesigned medical robots, such as with the use of UV technology. UV light can be combined with mobile robots to make disinfection services autonomous and more efficient. These trends are expected to boost the growth of the disinfection robots market over the forecast period of 2020 to 2030.

What else is in the report?

Persistence Market Research offers a unique perspective and actionable insights on the disinfection robots market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030 based on product (hydrogen peroxide vapor (HPV) robots and UV light robots), technology (semi-autonomous robots and fully-autonomous robots), and end user (hospitals, clinics & emergency care centers, diagnostic laboratories, pharmaceutical & biotech companies, airports, railway stations, shopping malls, production facilities, office buildings, and others), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Alginate Dressings Market To Get On To The Magnanimous Mode At US$ 1.1 Billion Sun, 11 Apr 2021 15:27:33 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701723.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701723.html persistencemarketresearch persistencemarketresearch

Wound dressing plays a crucial role in healing and management. Alginate dressings are the most preferred products to treat pressure ulcers, leg ulcers, infected surgical wounds, etc. which has led to a surge in their demand. Besides, introduction of new alginate dressing products with better functionalities by market players has also aided market growth. Increasing investments in new alginate dressing development and growing efforts for their distribution by key stakeholders are major factors expected to boost the growth of the alginate dressings market.

The global alginate dressings market is projected to be valued at US$ 1.1 Bn in 2030, and is expected to exhibit a CAGR of 3.5% during the forecast period (2020 – 2030).

Planning Forward? Access Sample Of Alginate Dressings Market Report! https://www.persistencemarketresearch.co/samples/26929

Companies covered in Alginate Dressings Market Report

  • 3M Co
  • Smith & Nephew Plc
  • ConvaTec Group Plc
  • Coloplast A/S
  • BSN medical GmbH
  • B. Braun Melsungen AG
  • Mölnlycke Health Care

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Alginate Dressings Market? https://www.persistencemarketresearch.co/methodology/26929

Key Takeaways from Alginate Dressings Market Study

  • Antimicrobial alginate dressings contributed for a larger revenue share than non-antimicrobial alginate dressings in the global alginate dressings market in 2019, owing to their high preference of use for wound healing.
  • High adoption of alginate dressings for the treatment chronic wounds is expected to result in notable market share of the chronic ulcers segment in the alginate dressings market.
  • Institutional sales contributed around three-fourth of value share by distribution channel due to increasing patient preference.
  • North America captured a greater revenue share among all regions, and is expected to be the most lucrative region in the global alginate dressings market during the forecast period.
  • Reluctant adoption and high cost of products are factors expected to affect the growth of the alginate dressings market around the globe.
  • Outbreak of the COVID-19 pandemic has had a moderate impact on the overall growth of the alginate dressings market, due to its adverse effect on the global economy and healthcare industry.

Increasing prevalence of chronic and traumatic wounds and continuous focus of key market players to develop advanced wound dressing products are projected to propel the global alginate dressings market over the coming years,” says a PMR analyst.

Planning To Introduce An Offbeat Product/Technology In The Alginate Dressings Market? Go To “Purchase Now” To Have Our Alginate Dressings Market Report! https://www.persistencemarketresearch.com/checkout/26929

Consolidation Activities:Imperative Strategy for Market Players

Increase in market consolidation activities by market players, including collaborations and partnerships, are characteristics of the overall competition among global alginate dressings market players. Manufacturers are focusing on collaborations with research institutes and universities to drive research & development in advanced wound care. For instance, in July 2017, Smith & Nephew collaborated with the University of Hull to drive research in the field of advanced wound care.

What else is in the report?

Persistence market research offers actionable insights and a unique perspective on the alginate dressings market, in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020–2030, based on alginate dressing type (antimicrobial alginate dressings and non-antimicrobial alginate dressings), indication (chronic ulcers and non-healing surgical wounds), and distribution channel (institutional sales and retail sales), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Nitrile Gloves Market To Move Away From Insipidness, Reach US$ 26.7 Billion Sun, 11 Apr 2021 15:27:11 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701722.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701722.html persistencemarketresearch persistencemarketresearch The growing pandemic of community infections owing to the emergence of new pathogens is expected to increase the demand for nitrile gloves across the world. The need to quell community and hospital-acquired infections is expected to drive the growth of the global nitrile gloves market.

Key product manufacturers operating in the market offer a wide range of products, such as disposable and reusable nitrile gloves. Owing to the non-availability of treatment for new pathogen infections and significant lag phase between the emergence of new pathogens and development of effective treatment and vaccines, there has been increasing need for nitrile gloves as a preventive measure.

Get Going With Sample Of Nitrile Gloves Market Report! https://www.persistencemarketresearch.co/samples/31892

Companies covered in Nitrile Gloves Market Report

  • Cardinal Health
  • Kimberly Clark Corporation
  • Top Glove Corporation Berhad
  • Dynarex Corporation
  • Ansell Limited
  • Adventa Berhad
  • Rubberex Corporation
  • 3M Company
  • Kossan Rubber Industry Ltd.
  • Hartalega Holdings Berhad
  • Supermax Corporation Berhad
  • Medline Industries, Inc.
  • B. Braun Melsungen AG

How About Re-Inventing The Methodical Wheel In The Nitrile Gloves Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/31892

Persistence Market Research predicts that the global nitrile gloves market will exhibit an impressive CAGR of 24% during the forecast period (2020-2030), to be valued at US$ 26.7 Bn by 2030-end.

Key Takeaways from Nitrile Gloves Market Study

  • By product type, powder-free gloves are expected to gain traction in the global nitrile gloves market during the forecast period.
  • Owing to the use of powder-free gloves for the prevention of primary infections and allergic side-effects, and to perform surgical procedures, the powder-free segment is the most dominating product type in North America and Europe nitrile gloves markets.
  • In terms of usage, disposable gloves are expected to gain more than 1/3 share in the nitrile gloves market share by 2030.
  • By sterility, sterile gloves are expected to hold more than 1/3 revenue share in the global nitrile gloves market by 2030, owing to high standard regulatory compliance requirements for medical nitrile gloves.
  • Under the end user segmentation, hospitals and ambulatory surgical centers segments are expected to collectively gain more than 2/3 market share in the nitrile gloves market by 2030.
  • North America is the highest revenue generating market by region, due to the high rate of COVID-19 pathogenic infections and 10X increase in the average selling prices of nitrile gloves. Europe is expected to offer lucrative opportunities, owing to higher incidence of hospital-acquired infections and increasing volume of innovative surgical procedures.

Keeping A Tab On Key Players In The Nitrile Gloves Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Nitrile Gloves Market Report! https://www.persistencemarketresearch.com/checkout/31892

“Disruptive unmet demand for medical gloves with 10X rise of average selling price, and WHO pushing for effective COVID-19 prevention, are expected to propel the growth of the global nitrile gloves market,” says a PMR analyst.

Accelerated Expansion & Acquisition by Leading Industry Players to Meet Unmet Demand in Nitrile Gloves Market

Leading manufacturers in the global nitrile gloves market are extensively focusing on the expansion of their manufacturing capabilities due to current disruptive demand. Governments are actively encouraging local manufacturers to prioritize emergency demand, specifically for public hospitals and healthcare setups.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the nitrile gloves market, in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of product type (powder-free gloves and powdered gloves), usage (disposable gloves and reusable gloves), sterility (sterile gloves and non-sterile gloves), and end user (hospitals, ambulatory surgical centers, clinics, diagnostic centers, and others) across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Biologics Contract Manufacturing Demand Market To Move Away From Stagnation, Reach 8 Million liters (MillionL) Sun, 11 Apr 2021 15:26:49 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701721.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701721.html persistencemarketresearch persistencemarketresearch Pharmaceuticals and biotechnology companies are outsourcing specific services from the early stages of drug development to biological contract manufacturing organizations to reduce drug manufacturing costs. Outsourcing increases drug manufacturing efficiency and facilitates flexible operational capabilities, which is expected to immensely boost biologics contract manufacturing demand.

Rising prevalence of chronic and lifestyle diseases is also anticipated to propel biologics contract manufacturing demand. Besides, continuous focus by manufacturers toward adopting technologically-advanced systems to manufacture novel biologics is also expected to accelerate the demand for biologics contract manufacturing over the forecast period.

Planning Forward? Access Sample Of Biologics Contract Manufacturing Demand Market Report! https://www.persistencemarketresearch.co/samples/31928

Companies covered in Biologics Contract Manufacturing Demand Market Report

  • BioXcellence (Boehringer Ingelheim GmbH)
  • Lonza Group AG
  • Samsung Biologics Co. Ltd.
  • Fujifilm Diosynth Biotechnologies (FUJIFILM Holdings)
  • AbbVie Contract Manufacturing (AbbVie Inc.)
  • WuXi Biologics (Cayman) Inc.
  • Patheon N.V. (Thermo Fisher Scientific Inc.)
  • Emergent BioSolutions Inc.
  • AGC Biologics
  • Ajinomoto Bio-Pharma (Ajinomoto Co., Inc.)
  • Avid Bioservices, Inc.
  • KBI Biopharma (JSR Life Sciences (JLS))
  • Catalent Inc.
  • Abzena Plc.

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Biologics Contract Manufacturing Demand Market? https://www.persistencemarketresearch.co/methodology/31928

Global biologics contract manufacturing demand is expected to reach at 8 Mn liters (MnL) in 2030, exhibiting an impressive CAGR of over 17% during the forecast period (2020 – 2030).

Key Takeaways from Biologics Contract Manufacturing Demand Study

  • Leading global CDMOs are focusing on expansion of their manufacturing capabilities with high flexibility and rapid operation capacity as biologics contract manufacturing demand is high. With the help of advanced single-use technologies, companies are able to cut batch manufacturing and cleaning time from 7 days to 1 day. This trend is expected to provide a competitive-edge to companies in terms of capacity, cost, convenience, and operational efficacy.
    • For instance, in Oct 2018, Thermo Fisher Scientific Inc. announced a US$ 50 million (€44 million) expansion at a CDMO plant in St Louis, Missouri, U.S., to add 16,000 L of single-use capacity due to extremely strong growth in demand for commercial biologic manufacturing. As per the company, the facility will be the largest outsourced single-use biologics site in North America.
  • With advancements in contract solutions, leading CDMOs are focusing on the expansion of their integrated capabilities from molecule-to-finished product. This trend is significant as the acceleration of development and speed to market is becoming more crucial for biopharmaceutical therapeutic developers.
    • For example, in July 2020, Avid Bioservices and Argonaut Manufacturing Services entered into an agreement to offer biotechnology and pharmaceutical clients integrated process development, drug substance manufacturing, and drug product parenteral manufacturing, to accelerate the development and commercialization of biopharmaceutical therapeutics.
  • Viral vector and vaccines contract development and manufacturing services are expected to gain significant traction due to the COVID-19 pandemic breakout and subsequent vaccine development programs.
    • For instance, in June 2020, AGC Biologics expanded its development capacities for pDNA services at the Heidelberg site, Germany, to meet the growing need for process development and manufacturing for plasmid DNA (pDNA).
  • Europe is expected to be the most lucrative region and with a revenue share of around one-third in global biologics contract manufacturing demand in 2020, owing to the presence of leading CDMO facilities in the region.

“Technological advancements to improve the manufacturing efficiency of biologics at low cost is expected to flourish market growth opportunities and provide a competitive advantage to market players in terms of innovation,” says a PMR analyst.

Planning To Introduce An Offbeat Product/Technology In The Biologics Contract Manufacturing Demand Market? Go To “Purchase Now” To Have Our Biologics Contract Manufacturing Demand Market Report! https://www.persistencemarketresearch.com/checkout/31928

Doubling Industry Capacity by 2022-2023 amid COVID-19 Pandemic

The COVID-19 pandemic is becoming an industry changing milestone by providing opportunities to global CDMOs - small as well big CDMO companies. Local government and industry funds are being targeted toward rapid expansion of industry capacity in order to meet the unmet demand for vaccine development and commercialization amid the COVID-19 crisis.

For instance, in June 2020, Fujifilm Diosynth Biotechnologies announced the investment of 100 billion Yen (US$ 928 Million) to expand its large-scale biologics production facility in Denmark.

Expansion of Manufacturing Capacity - Imperative Strategy for Market Players

Key players involved in biologics contract manufacturing are looking forward to expand their manufacturing capacities to meet global demand. Leading companies are expanding their production capabilities and capacities to become the preferred choice for innovative biopharmaceutical companies and hold on to a strong position in the market.

For instance, in January 2019, Boehringer Ingelheim Biopharmaceuticals China expanded its commercial manufacturing capacities. The company installed an additional bioreactor, all needed utility, and infrastructure for GMP operations.

What Does the Report Cover?   

Persistence Market Research offers a unique perspective and actionable insights on biologics contract manufacturing demand in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of platform (mammalian and microbial), application (commercial and clinical) product (monoclonal antibodies, recombinant proteins, vaccines, insulin, interferons, growth factors, and others), and therapeutic area (oncology, autoimmune disease, metabolic disease, ophthalmology, cardiovascular disease, infectious disease, neurology, respiratory disorders, and others), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Molecular Grade Plates Market To Witness An Extensive Growth With A CAGR Of 4.1% Fri, 09 Apr 2021 13:40:19 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701550.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701550.html persistencemarketresearch persistencemarketresearch

Chronic diseases such as cancer, viral infections, and cardio vascular disorders are constantly increasing across the world. Polymerase chain reaction (PCR) is a broadly-used test for the diagnosis of a wide variety of central nervous system (CNS) diseases, including genetic and autoimmune diseases, infections, and malignant neoplasms. With rising number of chronic disorders such as viral hepatitis B, viral hepatitis C, and other sexually-transmitted infections, the role of PCR is increasing, which, in turn, benefits the molecular grade plates market.

Molecular grade plates are used in a variety of applications, such as Real Time PCR, both qualitative and quantitative, nucleic acid purification, and DNA sequencing. These plates are built for common uses such as sample storage and other high throughput applications.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/32283

Companies covered in Molecular Grade Plates Market Report

  • Thermo fisher scientific
  • Merck KGA
  • Bio-Rad
  • Takara Bio, Inc.
  • QIAGEN N.V.
  • Pall Corporation
  • Eppendorf Corporate
  • Tarsons
  • Applied Biological Materials Inc.
  • Greiner AG
  • Brooks Life Sciences
  • Corning Incorporated
  • Cytiva

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/32283

The COVID-19 pandemic has positively impacted the global molecular grade plates market. PCR tests have been found effective in diagnosing COVID-19. Currently, these tests are for people at risk of developing severe COVID-19. However, the pandemic has created a vast opportunity for the molecular biology industry to grow, and this is also leading to increased adoption of diagnostic products and consumables.

Key Takeaways from Molecular Grade Plates Market Study   

  • Holding over 60% market share, the PCR plates segment will experience the maximum positive impact during the COVID-19 pandemic, due to the rising adoption as a COVID19 diagnostic test.
  • Biotechnology companies are expected to hold more than half of the revenue share in the molecular grade plates market during the forecast period.
  • North America is the most lucrative regional market, owing to technological advancements coupled with rising research & development activities in the region.
  • With high demand for PCR testing, the COVID-19 pandemic is having a positive impact on the growth of the global molecular grade plates market.

“Growing manufacturers’ focus on developing new technologies in molecular biology applications, along with increasing funding in life science research are expected to propel growth of the global molecular grade plates market over the coming years,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32283

Increasing Life Science Research Activities Coupled with Innovative Business Strategies by Market Leaders Likely to Drive Market Growth

Increased adoption of new technologies in life science research, such as virtual clinical trials, telemedicine, and artificial intelligence will change traditional medical research and improve diversity. There have been many challenges in research, but despite this, the life sciences industry is continuously investing in R&D. This will increase revenue generation from the biotech industry as well.

  • For instance, commercialization of gene and cell therapies in the future will change the entire medicine world.

Key players in the molecular grade plates market are focusing on acquisition and partnerships with small players and suppliers for expansion of market presence. Manufacturers are adopting this strategy to expand their footprint across regions. Moreover, they are also focusing on research & development activities for the application of molecular grade plates in various research applications

  • For instance, in May 2018, Greiner Bio-One North America, Inc. acquired 3D Cell Culture Technology, previously owned by Nano 3D Biosciences, Inc.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the molecular grade plates market in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, on the basis of product (PCR plates, deep well plates, and sample preparation filter plates), application (PCR, next-gen sequencing (NGS), and sample storage), and end user (biotechnology companies and research & academic institutes), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Biocompatible Materials Market To Rescind With A CAGR Of 9% Fri, 09 Apr 2021 13:39:57 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701549.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701549.html persistencemarketresearch persistencemarketresearch

Biocompatible materials can be used in dental, orthopaedic and cardiovascular implants, drug delivery, hearing aids, tissue engineering scaffolds, prosthesis, cosmetics, and other medical device, as they are easily mouldable, biodegradable, and cost-effective. Biocompatible polymers experience harmless decomposition, which accelerates the healing process in the body. Moreover, manufacturers are focusing on developing their biocompatible portfolios and expanding their application for various diseases such as orthopedic disease and cardiovascular disease.

High prevalence of orthopedic and cardiovascular disorders and technological advancements represent additional opportunities for manufacturers. Hence, increasing investments by companies for advanced product development that are non-toxic and non-immunogenic are also expected to create growth opportunities for the biocompatible materials market. Approval and commercialization of novel biocompatible materials are providing a huge opportunity in developing countries.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/32234

Companies covered in Biocompatible Materials Market Report

  • Dupont
  • Ensinger
  • Stratasys Ltd.
  • Covestro AG
  • Foster Corporation
  • Merck KGaA
  • BASF SE (Exxon Mobil Corporation)
  • Wacker Chemie AG
  • Celanese Corporation
  • Royal DSM
  • Evonik Industries AG
  • Shin-Etsu Chemical Co. Ltd.
  • Henkel AG & Co.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/32234

According to a latest report published by PersistenceMarketResearch, the global biocompatible materials market is anticipated to experience a CAGR of over 9% during the forecast period (2020 – 2030).

 Key Takeaways from Biocompatible Materials Market Study

  • The synthetic polymers segment, under material type, is expected to hold significant revenue share in the biocompatible materials market.
  • Surgical & medical instruments are the most attractive applications with the highest share, followed by biocompatible implants. These segments are expected to grow at a higher rate as compared to other applications.
  • In terms of regional growth, North America, Europe, and Asia Pacific are manufacturing hubs for biocompatible materials, and are anticipated to witness rapid growth in the global biocompatible materials market.
  • The COVID-19 outbreak has created hindrances for the growth of the biocompatible materials market, which will persist in the first half of 2021.

“Upsurge in demand for medical devices and biopharmaceutical products for treatment and diagnosis purposes will boost the global biocompatible materials market over the coming years,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32234

Collaborations & Acquisitions – Key Strategies amongst Market Players

Leading players in the biocompatible materials market are strengthening their product portfolios by launching new products.

  • For instance, in June 2020, Ensinger launched Laser direct structuring (LDS): TECACOMP LCP LDS 1049426 black, based on a Liquid Crystal Polymer (LCP).

Various players in the biocompatible materials market are focusing on growth strategies such as expansion, collaborations, and agreement licences.

  • In September, 2018, DuPont escalated the manufacturing capacity of the Kinston, North Carolina unit, for elevated production of the bio-based, high-performance DuPont™ Sorona® polymer.
  • In May 2019, Stratasys partnered with Solvay for an authorized materials partner program. The partnership will leverage the deposition modelling process of Stratasys with FDM Technology™ in 3D printing applications.
  • In October 2020, Covestro acquired the Resins & Functional Materials business (RFM) segment from Royal DSM. The acquisition will strengthen the portfolio of sustainable coating resins.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the biocompatible materials market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2020, on the basis of material type (polymers, metal, ceramic, and composites), application (surgical & medical instruments, implants, drug delivery, and others), end user (medical device manufacturers, academic and research institutes, and biopharmaceutical & pharmaceutical companies), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Serum Free Media Market To Witness A Penurious CAGR Of 7.3% Fri, 09 Apr 2021 13:39:35 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701548.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701548.html persistencemarketresearch persistencemarketresearch

Serum-free media gives more consistent cell growth and helps eliminate possible errors by minimizing the percentage of uneven growth among cell cultures. Consistency in cell culture coupled with superior cell growth with increased productivity makes it easier to use serum-free media for cell culture growth in biopharmaceutical production, research, and development.

Increasing focus on biopharmaceuticals to treat chronic diseases is fuelling biopharmaceutical production. The contribution of biopharmaceuticals in the healthcare industry is rising due to superior efficacy as compared to conventional drugs. Downstream processes are often regarded as a bottleneck of the biopharmaceutical industry, but it is increasing the usage of serum-free media for cell culture growth.

Get Sample Copy of Report @ https://www.persistencemarketresearch.co/samples/15373

Companies covered in Serum Free Media Market Report

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GE Healthcare
  • Lonza
  • Corning Incorporated
  • Irvine Scientific
  • STEMCELL Technologies Inc.
  • PAN Biotech
  • MP Biomedicals, LLC
  • PromoCell GmbH

Get To Know Methodology of Report @ https://www.persistencemarketresearch.co/methodology/15373

Increasing number of personalized targeted products, rise of advanced manufacturing technologies, continuously improving manufacturing scalability, and alternative downstream processes are some of the key drivers of increasing biopharmaceutical production. Moreover, production of serum-free media is largely concentrated in North America, Europe, and some parts of Asia Pacific, whereas, it has limited availability in untapped biopharmaceutical markets such as the Middle East & Africa, Latin America, and some countries of Asia.

Thus, it has huge scope for manufacturing to improve availability and provide cost-effective products in Latin America and MEA.

According to a latest report published by PersistenceMarketResearch , the global serum-free media market is expected to witness a CAGR of more than 7% during the forecast period (2020 – 2030), to close in on a valuation of US$ 3 Bn by the end of 2030.

 Key Takeaways from Serum-Free Media Market Study

  • The CHO cell media segment under media type is expected to hold more than twenty percent of revenue share in the serum-free media market.
  • By end user, biopharmaceutical companies held the highest market share in 2019. Serum-free media is significantly used in drug development and cell culture, which is anticipated to drive demand over the coming years.
  • Countries such as the U.S., Germany, India, and China are expected to experience significant growth in the global serum-free media market over the coming years, due to increase in drug development activities in these regions.
  • The COVID-19 outbreak has had a negative impact on the global serum-free media market, as a result of lockdowns and closing of manufacturing facilities across regions.

“Rise in biopharmaceutical industries and demand for cell therapies for cancer treatment will boost the global serum-free media market,” says a PersistenceMarketResearch analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/15373

Collaboration & Acquisitions – Key Strategies amongst Market Players

Leading players in the serum-free media market are strengthening their product portfolios by launching new products.

  • For instance, in March 2016, Lonza launched PowerCHO Advance™ Media for improved protein-production yields.

Various players in the serum-free media market are focusing on growth strategies such as collaborations and agreement licences.

  • In June 2018, Fujifilm completed the acquisition of Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media.
  • In December 2019, Sartorius announced the acquisition of a majority stake in cell culture media specialist Biological Industries.
  • In May 2017, Lonza acquired cell and gene contract manufacturer PharmaCell.
  • In April 2017, Thermo Fisher Scientific completed the acquisition of Brammer Bio, a viral vector manufacturer for gene and cell therapies.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on serum-free media in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of media type (protein expression media, stem cell media, hybridoma media, primary cell media, insect cell media, immunology media, CHO cell media, and chemically-defined media), animal source (camelids and sharks), and end user (biopharmaceutical companies, clinical research organizations, and academic research centers), across seven key regions.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Volumetric Pumps Market To Mark Robustness In The Form Of A Robust CAGR ~4.8% Fri, 09 Apr 2021 13:39:12 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701547.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701547.html persistencemarketresearch persistencemarketresearch

Increasing prevalence of cancer and other chronic disorders, and rise in number surgical procedures across the globe, are expected to surge demand for volumetric pumps. Additionally, presence of a well-structured regulatory framework for using volumetric pumps in regions such as North America and Europe has been playing an important role in shaping the prospects of the global volumetric pumps market.

The COVID-19 pandemic is having a significant positive impact on the volumetric pumps market, as a result of shortage of infusion pumps to treat patients using nebulization support with rising incidence of dosing-errors cases. To overcome dosing-errors and inaccuracy in delivering drugs, surge in demand for volumetric pumps is being witnessed.

Want Insights To Volumetric Pumps Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/32174

Companies covered in Volumetric Pumps Market Report

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Terumo Corporation
  • ICU Medical, Inc.
  • Becton, Dickinson and Company
  • Smiths Medical
  • Woodley Equipment Company Ltd.
  • Mindray Medical International Ltd.
  • ADOX S.A
  • Sino-Hero (Shenzhen) Bio-Medical Electronics Co. Ltd.
  • Guangzhou Huaxi Medical Science Technology Co. Ltd.
  • ASCOR
  • Shenzhen Shenke Medical Instrument Technical Development Co. Ltd.
  • Daiwaha corp. ltd.
  • CONTEC MEDICAL SYSTEMS Co. Ltd.

Planning To Conclude Your Strategy On A Decisive Note In The Volumetric Pumps Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/32174 

The global volumetric pumps market is estimated to expand at a CAGR of more than 5% over the forecast period (2020-2030)

Key Takeaways from Volumetric Pumps Marker Study

  • Based on product type, peristaltic pumps dominated the volumetric pumps market, owing to their advantage of lowering dose-error and delivering drugs with accurate flow rates using the peristalsis mechanism.
  • The chemotherapy/ oncology segment is expected to obtain maximum revenue share over the forecast period, due to rising incidence of cancer and the treatment given in continuous cycles.
  • Among all end users, the hospitals segment hold a high market revenue share, due to the availability of advanced facilities and experienced professionals across hospitals around the world.
  • The COVID-19 pandemic crisis is having a positive effect on the demand for volumetric pumps across the world.

 “Rising incidence of dosing-error cases and inaccuracy in drug delivery are expected to shift preferences toward advanced volumetric pumps, which will propel the growth of the global volumetric pumps market over the coming years,” says a PMR analyst.

How About Knowing The Product/Technology Driving The Volumetric Pumps Market Before Investing Therein? Click The “Purchase Now” Button Of Our Volumetric Pumps Market Report! https://www.persistencemarketresearch.com/checkout/32174    

Volumetric Pumps Market: Key Strategies amongst Players

Worldwide, leading key players in the volumetric pumps market are extensively focusing on technological advancements, acquisition, and collaborations to expand their product portfolios. These key strategies are expected to propel the growth of the volumetric pumps market too. Players dealing in hospital supplies are increasingly targeting the volumetric pumps market for acquiring leading companies or those ones facing a large number of product recalls.

  • For instance, in February 2015, Pfizer acquired Hospira, as the latter had been facing one of the highest product recalls in the industry, which was then acquired by ICU Medical in 2017.
  • Additionally, Carefusion was acquired by Becton Dickinson, as the latter wanted to expand its market share in the surgical supplies segment.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the volumetric pumps market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030. The market has been segmented on the basis of product type (peristaltic and cassette/ piston), application (chemotherapy/ oncology, pediatrics/ neonatology, analgesia, and hematology), and end user (hospitals, ambulatory surgical centers, clinics, and others), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Triple Negative Breast Cancer Treatment Market To Embark Upon A Double Digit CAGR 4.7% Fri, 09 Apr 2021 13:38:50 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701546.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701546.html persistencemarketresearch persistencemarketresearch

Significant rise in awareness about preventative therapies is anticipated to drive the triple-negative breast cancer treatment market during the forecast period. According to WHO, the risk of developing cancer before the age of 75 years is around 20.2% and that of dying from cancer before the age of 75 years is around 10.6%. According to the American Cancer Society, in 2019, around 268,600 new cases of invasive breast cancer were diagnosed among women and approximately 2,670 cases were diagnosed in men. Thus, rising prevalence of breast cancer among the population is expected to propel the growth of the triple-negative breast cancer treatment market over the coming years.

Get Going With Sample Of Triple-Negative Breast Cancer Treatment Market Report! https://www.persistencemarketresearch.co/samples/14305 

Companies covered in Triple Negative Breast Cancer Treatment Market Report

  • AstraZeneca plc.
  • Pfizer, Inc.
  • F. Hoffman – La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Mylan N.V.
  • Eli Lilly and Company
  • Celgene Corporation
  • Sanofi S.A.
  • Johnson & Johnson Services, Inc.

How About Re-Inventing The Methodical Wheel In The Triple-Negative Breast Cancer Treatment Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/14305

Persistence Market Research predicts that the global triple-negative breast cancer treatment market will exhibit a CAGR of around 5% over the forecast period (2020-2030).

Key Takeaways from Triple-Negative Breast Cancer Treatment Market Study    

  • Based on drug, paclitaxel is expected to gain traction in the global triple-negative breast cancer treatment market during the forecast period, owing to its efficacy.
  • The hospital pharmacies segment is expected to be the most attractive segment in the global triple-negative breast cancer treatment market by distribution channel, and will hold the highest market share.
  • North America will dominate the global triple-negative breast cancer treatment market by region over the forecast period, owing to growing population, rising prevalence of breast cancer, and excessive consumption of tobacco and alcohol.
  • The triple-negative breast cancer treatment market is expected to experience a short-term negative impact during the COVID-19 pandemic crisis, owing to labor shortage, transportation restrictions, supply chains issues, and shortage of medical instruments for cancer.

Rising prevalence of breast cancer, increased focus on innovation of robust drug pipeline and combination therapies, developments in therapeutic areas, and growing concerns about maintaining environmental hygiene after the COVID-19 outbreak are factors expected to contribute to the growth of the global triple-negative breast cancer treatment market,” says a PMR analyst.

Keeping A Tab On Key Players In The Triple-Negative Breast Cancer Treatment Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Triple-Negative Breast Cancer Treatment Market Report! https://www.persistencemarketresearch.com/checkout/14305

Accelerated Expansion and Acquisitions & Collaborations by Leading Industry Players to Meet Unmet Demand

Leading manufacturers in the global triple-negative breast cancer treatment market are extensively focusing on expansion of their manufacturing. Government initiatives such as awareness programs, investments by regional manufacturers, and increasing healthcare expenditure are some of the key trends expected to drive the triple-negative breast cancer treatment market over the coming years.

  • For instance, in April 2018, Servier acquired Shire’s oncology business to gain direct commercial access in the U.S. At present, Servier offers Oncaspar in the U.S. Prior to this, Shire and Baxalta were involved in a US$ 32 billion merger in 2016.
  • Additionally, in January 2018, Sanofi announced its plan to acquire ELOCTATE.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the triple-negative breast cancer treatment market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of drug (doxorubicin, cyclophosphamide, paclitaxel, docetaxel, carboplatin/cisplatin, and others) and distribution channel (hospitals, cancer research institutes, and retail clinics), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Single-Domain Antibody Platforms Market To Witness A Growth Of 10%, To Reach Fri, 09 Apr 2021 13:38:28 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701545.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701545.html persistencemarketresearch persistencemarketresearch

Monoclonal antibodies are highly efficient as therapeutics against viral infections, immune diseases, and cancer. However, they are large in size and unable to access some epitopes, besides the production cost being high. Hence, single-domain antibodies (sdAbs) is an alternative for monoclonal due to larger number of accessible epitopes, smaller size, relatively low production costs, and potent inhibitors against immune and viral diseases. Currently, single-domain antibodies are being developed against a number of viruses, including influenza viruses, HIV, hepatitis C virus (HCV), enteric viruses, and respiratory syncytial virus (RSV).

Technological advancements in single-domain antibody platforms such as production of bispecific and multi-specific antibodies to target particular antigens during therapeutic developments are some other factors that will boost the growth of the single-domain antibody platforms market.

Planning Forward? Access Sample Of Single-Domain Antibody Platforms Market Report! https://www.persistencemarketresearch.co/samples/28351

Companies covered in Single Domain Antibody Platforms Market Report

  • Creative BioLabs A
  • Synbio Technologies
  • ProSci Incorporated
  • BioCat GmbH
  • Antibody Design Labs
  • GenScript
  • Oak BioSciences, Inc.
  • Rockland Immunochemicals, Inc
  • Hybrigenics Services
  • NeoClone Biotechnology International LLC
  • Kaneka Eurogentec S.A
  • ProteoGenix

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Single-Domain Antibody Platforms Market? https://www.persistencemarketresearch.co/methodology/28351

According to a latest report published by PMR, the global single-domain antibody platforms market is projected to be valued at US$ 22 Mn in 2020, and is expected to witness an impressive CAGR of around 10% during the forecast period (2020 – 2030).

 Key Takeaways from Single-Domain Antibody Platforms Market Study     

  • The bispecific single-domain antibody segment under platform type is expected to contribute more than 30% of revenue share in the single-domain antibody platforms market.
  • By application, therapeutic development accounted for the highest market share in 2019. Single-domain antibodies are highly effective in immune therapy, and antiviral therapy is anticipated to drive demand for single-domain antibody platforms.
  • Developing countries such as India, China, and South Africa are projected to register positive growth over the coming years, due to increase in drug development activities in these regions.
  • Leading players are focused on improving their service and established collaborations with research institutes and provide customized products.
  • The COVID-19 outbreak has created a positive impact on the single-domain antibody platforms market, with increased demand for antibodies in the treatment against COVID-19.

“Rise in prevalence of infectious disease and demand for immunotherapy for preventive treatments will boost the global single-domain antibody platforms market,” says a PMR analyst.

Planning To Introduce An Offbeat Product/Technology In The Single-Domain Antibody Platforms Market? Go To “Purchase Now” To Have Our Single-Domain Antibody Platforms Market Report! https://www.persistencemarketresearch.com/checkout/28351

Collaborations & Acquisitions – Key Strategies amongst Market Players

Leading players in the single-domain antibody platforms market are strengthening their product portfolios by launching new products.

  • For instance, in July 2020, Creative Biolabs developed over 400 types of therapeutic antibodies that can be applied to the study on COVID-19 drugs.
  • ProSci Incorporated announced the release of multiple single-domain antibodies against the human programmed death ligand 1 (PD-L1).
  • In May, 2016, Antibody Design Labs offered a complete line of services for single-domain antibody development, including single-domain antibody phage libraries, immunization, and large-scale production of recombinant single-domain antibodies

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the single-domain antibody platforms market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of platform type (multi-specific single-domain antibody, bispecific single-domain antibody, multivalent single-domain antibody, and mono-specific single-domain antibody), animal source (camelids and sharks), application (diagnostic laboratories, therapeutic development, and research & development activities) and end user (diagnostic laboratories, clinical laboratories, academic and research institutes, and pharmaceutical and biotechnology companies), across seven key regions.

 

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

]]>
The Antibiotic Resistance Market To Quell Covid-19; To Reach US$ 12.6 Bn Thu, 08 Apr 2021 07:16:59 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701048.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701048.html persistencemarketresearch persistencemarketresearch

Antibiotic resistance is one of the biggest public health concerns today. In the U.S., over 2 million people suffer from an antibiotic-resistant infection annually. Growing mortality rate due to these infections has generated a gateway for pharmaceutical manufacturers to develop novel antibiotics. Fighting this threat is a national and public health priority that needs a collaborative approach among healthcare providers and governments. Human overuse of antibiotics leads to the development of antibiotic resistance, which, in turn, demands newer antibiotics.

Escherichia coli and Klebsiella pneumonia are highly resistant to the class of antibiotics called Carbapenem. Carbapenem-resistant Enterobacteriaceae (CRE) infection is a dangerous condition, because these microbes can cause infections in almost all parts of the body. Some of the very severe and common infections include urinary tract infections, ventilator-associated pneumonia bloodstream infections, and intra-abdominal abscesses. These infections are more dangerous as they are resistant to Carbapenem antibiotic drugs, which are considered to be the last resort of defence to treat multidrug-resistant bacterial infections.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/27895

Companies covered in Antibiotic Resistance Market Report

  • Pfizer Inc
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Johnsons & Johnson
  • Baxter Healthcare Corporation
  • Zydus Cadila
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Dr. Reddy’s Laboratories Ltd.
  • Mayne Pharma Group Limited.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • Shanghai Pharmaceutical Group Co., Ltd.
  • Yuhan Corporation
  • Abbott Laboratories

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/27895

Among all the regions, Asia Pacific countries are regarded as high CRE-prevalent regions, where the rate of CRE detection has been continuously increasing.

According to a latest report published by Persistence Market Research, the global antibiotic resistance market is projected to be valued at US$ 12.6 Bn by the end of 2031, witnessing a steady CAGR of over 4% during the forecast period (2021 – 2031).

Key Takeaways from Antibiotic Resistance Market Study        

  • Beta lactam antibiotics are expected to contribute more than 25% of the revenue share to the market by 2031. These antibiotics target a broad range of microbes, leading to their higher adoption.
  • By distribution channel, hospitals pharmacies will lead by acquiring more than half of the market share. Most antibiotic-resistant infections are hospital-acquired, and hence, hospitals are major treatment providers.
  • By indication, complicated urinary tract infections (CUTIs) are expected to dominate the market, owning to their higher prevalence, especially in the female population. These infections are common in developing regions with poor hygiene practices.
  • North America represents the largest regional market for antibiotic resistance, with one-fourth global market share.
  • Key players are focused on strengthening their clinical pipelines with new discoveries of antibiotics and combination therapies.
  • The COVID-19 outbreak moderately affected the market. Demand for antibiotics during lockdowns was low as the sole focus was attending COVID-19 patients.
  • Demand for antibiotics in Asia Pacific countries, especially India and China, is unmatched. Antibiotic usage in overwhelming in these countries, leading to increased rates of antibiotic resistance, expected to expand at CAGRs above 5% through 2031.
  • The U.S. market holds a major share accounting more than 90% of the total North America market.

“Emergence of multi-drug-resistant bacteria due to excess consumption of antibiotics is anticipated to accelerate antibiotic resistance market growth,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/27895

Strategic Partnerships and Funding by Key Players Aiding Market Expansion

Prominent leaders in the antibiotics industry have pledged to fund a significant amount to bolster the research & development of new antibiotics.

  • For instance, Pfizer has assured to invest US$ 100 Mn in R&D of novel antibiotic discovery. This investment will go into its Antimicrobial Resistance (AMR) Action Fund.
  • Novartis partnered with over 20 prominent pharmaceutical companies to tackle antibiotic resistance by contributing to the Antimicrobial Resistance (AMR) Action Fund.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the antibiotic resistance market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031, on the basis of drug class (beta lactam antibiotic, cephalosporin, quinolones antibiotics, macrolide antibiotics, tetracycline, oxazolidinones and others), by pathogen, (staphylococcus aureus, streptococcus pneumonia, neisseria gonorrhoeae, enterococcus faecium, escherichia coli, klebsiella pneumonia, shigella, clostridium difficile, and others), disease (community acquired bacterial pneumonia (CABP), hospital acquired bacterial pneumonia/ ventilator (HABP/VABP), complicated urinary tract infections (CUTI), complicated intra-abdominal infections (CIAI), blood stream infections (BSI), abdominal infection and diarrhoea [clostridium difficile infections (CDI) & shigella], acute bacterial skin and skin structure infections (ABSSSI), and drug resistant gonorrhoeae), mechanism of action (Cell wall synthesis inhibitors, protein synthesis inhibitors, DNA synthesis inhibitors, RNA synthesis inhibitors and others), and distribution channel (hospitals pharmacies, retail pharmacies, and online pharmacies), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>
The Single Use Bioprocess System Market To Settle At US$ 4.4 Bn Thu, 08 Apr 2021 07:16:37 +0200 http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701047.html http://content.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/701047.html persistencemarketresearch persistencemarketresearch

Growing demand for single-use bioprocess systems due to their advantages of lesser cross-contamination chances provides a strong foothold for their use in the biopharmaceutical industry. Pharmaceutical and biotechnology companies are looking forward to continuous manufacturing of pharma products with optimizing speed and sterility assurance, which is expected to surge demand for single-use bioprocess systems. Use of disposable products for bioprocessing application enhances upstream and downstream processes with better safety, sterility, and reliability. Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.

Increasing investments toward manufacturing plant expansion and rising emphasis on low-cost disposable bioprocess product development by key market players are other major factors expected to aid market growth. The global single-use bioprocess systems market was valued at US$ 4.4 Bn in 2020, and is expected to exhibit a CAGR of close to 20% over the forecast period (2020 – 2030).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12142

Companies covered in Single Use Bioprocess System Market Report

  • Thermo Fisher Scientific Inc.
  • Sartorius Stedim Biotech
  • Danaher Corporation
  • Merck Millipore
  • Eppendorf AG
  • Celltainer Biotech B.V.
  • Applikon Biotechnology
  • Cellexus Ltd.
  • Parker Hannifin Corp
  • Mettler-Toledo International, Inc.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12142

Key Takeaways from Single-use Bioprocess Systems Market Study

  • The bioreactor segment by component held maximum value, owing to growing use of single-use bioreactors for cell culture and fermentation processes.
  • By application, GMP and commercial production captured a notable revenue share of more than 71%.
  • Increasing adoption of single-use bioprocess systems in biopharmaceutical companies is expected to result in remarkable revenue share of this segment.
  • North America is a most lucrative market with a revenue of around 34% in 2020; however, it will lose some of its market share over the next ten years.
  • Growing healthcare expenditure and increasing demand for low-cost biologics in Asian countries are expected to propel market growth in the region to more than one-third of the global share by 2030.
  • The markets in Russia, China, and Spain are anticipated to expand at CAGRs of 16%, 18.4%, and 17%, respectively, through 2030.

“Growing demand for disposable bioprocess systems to improve the manufacturing speed and efficacy of biologics at low cost is expected to flourish market growth and provide a competitive advantage to players,” says a Persistence Market Research analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12142

Expansion of Manufacturing Capacity – Imperative Strategy for Market Players

Key market players in the single-use bioprocess systems market are looking forward to expanding their manufacturing capacities by establishing new bioprocess facilities to meet global demand. Leading companies are also opening new product distribution facilities across regions.

For instance, in June 2017, Parker Hannifin opened a new parker bioscience filtration division in Birtley, the U.K., and Oxnard, California, in the U.S., to deliver international bioprocessing, food and beverage, and healthcare solutions.

What else is in the report?

Persistence Market Research offers actionable insights and unique perspective on the single-use bioprocess systems market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020–2030, based on component (bioreactors, mixers, bioprocess containers, transfer and storage bags, sampling systems, filtration systems, chromatography columns, probes & sensors, tubing assemblies, connectors & clamps, and filling systems), application (research & development (R&D) and GMP and commercial production), and end user (biopharmaceutical companies, contract research organizations, contract manufacturing organizations, and research institutes), across seven key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

 

]]>